The largest database of trusted experimental protocols

14 protocols using s8830

1

Protein Expression Analysis of Skin Flap

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein in skin flap was collected by RIPA lysate (R0278, Sigma-Aldrich, Missouri, USA) mixed with protease inhibitor (S8830, Sigma-Aldrich, Missouri, USA) in order to determine the protein levels of RIP1, RIP3, MLKL, PGAM5, Drp1, MKP-1, p-ERK1, p-ERK2, ERK1 and ERK2. The concentration of total protein was evaluated by BCA kit (Sigma-Aldrich, Missouri, USA) in the first place to estimate the loading volume of samples onto the SDS-PAGE for separation. Parameter for electrophoresis was 100 V for 2 h. PVDF membrane was used for the transferring of protein separated. Following the blocking of membrane for 60 min, primary antibodies against RIP1 (CST, #3493, 78 kD, 1:1000), RIP3 (Abcam, ab56164, 57 kD, 1:1000), MLKL (CST, #37705, 54 kD, 1:1000), PGAM5 (Abcam, ab126534, 32 kD, 1:1000), Drp1 (Abcam, ab56788, 82 kD, 1:1000), MKP-1 (CST, #3493,78 kD, 1:1000), p-ERK1/2 (Abcam, ab50011,42–44 kD, 1:1000), ERK1/2 (Abcam, ab17942, 42–44 kD), GAPDH (Abcam, ab8245, 36kD, 1:2000) were incubated on the membrane at 4 °C overnight. Next day, after the washing of membrane for 3 times, primary antibodies were probed by Goat anti-rabbit secondary antibody (Abcam, ab205718, 1:2000) and developed by ECL (#6883, SignalFire™ ECL Reagent) after washing by PBST (PBS with 0.1% Tween).
+ Open protocol
+ Expand
2

Tissue Extraction and Protein Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The uterine tissue (30 mg; endometrium and myometrium separate) was homogenized on ice in RIPA lysis buffer (5 mM EDTA, 150 mM NaCl, 50 mM TRIS, 0.1% SDS, 1% Triton X-100, 0.5% sodium deoxycholate, and a protease inhibitor from Sigma-Aldrich, S8830, pH 7.4). The obtained lysate was centrifuged at 10,000× g for 20 min at 4 °C, and the supernatant was transferred to a fresh tube and sonicated. The protein concentration was estimated according to Bradford’s method. The lysate was stored at −80 °C until further analysis.
+ Open protocol
+ Expand
3

Western Blot Analysis of ATG5 and LC3

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in SDS-PAGE buffer containing a collection of protease inhibitors (Sigma-Aldrich S8830). The lysate was then heated to 100ºC for 5 min. Aliquots containing 40 μg of protein per well were used for western blot analysis. For the ATG5 studies, the truncated ATG5 fragment represents amino acids 1–193 from the 276 that comprise ATG5. The antibody used for detection (Abgent) was raised against residues 1–30 at the N-terminal end and 209–238 toward the C-terminal end. This can detect both ATG5 and the 24 kDa fragment (7 (link)). Simon (personal communication) reported that this fragment is unstable and requires the presence of protease inhibitors during isolation procedures. For assessing level of LC3 I and II, an antibody to the murine LC3 protein was provided by Proteintech Group, Inc., Chicago, IL. Electrophoresis was carried out on 4–10% tris-gly acrylamide gels and the proteins transferred to polyvinylidene fluoride membranes. The membranes were probed with the specified antibody, followed by a1 hr incubation with an alkaline phosphatase-coupled secondary antibody at room temperature (Vistra ECF western blot reagent, Amersham). A substrate is then cleaved by phosphatase activity to form a fluorescent product that is detected with a Storm imaging system (Molecular Dynamics).
+ Open protocol
+ Expand
4

Purification of His-Tagged Proteins from E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasmids expressing proteins with an N-terminal hexahistidine tag were transformed in E. coli BL21 strain. Cells were grown in Terrific Broth (TB) at 37 oC. The expression was induced at 30 oC or 16 oC by addition of isopropyl β-D-1-thio-galactopyranoside (IPTG) to a final concentration of 1 mM at OD(600) = 0.6. The cells were harvested after 16 h of expression and lysed by sonication in lysis buffer (50 mM PBS with 150 mM NaCl at pH 7.4, 5 mg/ml DNAse, 5 mM MgCl2, and 1 mM phenylmethylsulfonyl fluoride (PMSF), and a cocktail of protease inhibitors (Sigma Aldrich; S8830)). After lysis, the mixture was incubated on ice for 2 h for DNA digestion. The insoluble material was removed by centrifugation and the supernatant was incubated overnight with Ni-NTA agarose beads (Thermo Fisher) at 4 oC in a rotator-mixer. The protein-loaded Ni-NTA column was washed twice with 20 column volumes of N1 buffer (50 mM PBS, 300 mM NaCl, 30 mM imidazole, pH 7.4) and twice N2 buffer (50 mM PBS, 150 mM NaCl, 10 mM imidazole, pH 7.4). The bound protein was eluted with N3 buffer (150 mM PBS pH 7.4, 300 mM imidazole). The protein fractions were eventually dialyzed with cassette Slide-A-Lyzer Dialysis Cassettes (Thermo Fisher) against 50 mM PBS, 150 mM NaCl pH 7.4.
+ Open protocol
+ Expand
5

Western Blot Analysis of OPA1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested and washed with PBS, and the cell pellet was resuspended in lysis buffer (10 mM Tris-HCl [pH 7.5], 150 mM NaCl, 4% glycerol, 1% Triton X-100, 0.1% sodium deoxycholate, 0.05% SDS) supplemented with protease inhibitors (S8830, Sigma-Aldrich). After 30 min incubation on ice, the supernatant was cleared from insoluble debris by centrifugation (30 min, 15,000g, 4°C). Forty micrograms of total protein lysate was loaded per lane, separated by 12% SDS-PAGE, and blotted onto a polyvinylidene fluoride (PVDF) membrane. After being blocked with 5% BSA/TBST for 1 h at room temperature, the membrane was incubated overnight at 4°C with an OPA1-specific antibody (1:1,000 diluted, mouse anti-OPA1 clone 18, cat. no. 612,607; BD Biosciences, Heidelberg, Germany) in blocking buffer. As loading control, a mouse anti-GAPDH antibody (Merck, Chemicon, MAB374) was used. A peroxidase-conjugated goat anti-mouse antibody (NB7539, Novus) was used as secondary antibody, followed by enhanced chemiluminescence (ECL) detection. Relative protein levels were calculated based on band intensity quantifications using ImageLab software (Bio-Rad).
+ Open protocol
+ Expand
6

Western Blot Analysis of PBMC Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 5 × 106 PBMCs were washed twice with 1X PBS and centrifuged at 1500 rpm for 5 min. Cells were lysed in a 1X RIPA buffer containing 150 mM NaCl, 1% NP-40 (Sigma Aldrich; NP40S), 50 mM Tris-HCl, pH 8, 0.5% deoxycholic acid (Sigma Aldrich, D6750), 0.1% SDS (Sigma Aldrich, 71736), protease (Sigma Aldrich; S8830) and phosphatase inhibitors (Sodium Orthovanadate; Sigma Aldrich; S6508) (Sodium Fluoride; Sigma Aldrich; S7920). Then, 15 µg of protein lysates was subjected to electrophoresis on 4–20% SDS-PAGE gradient gels (NuSep, Germantown, MD, USA; NN12-420), according to the manufacturer’s instructions. Then, the gels were transferred to nitrocellulose membranes (Bio-Rad, 162-0115) for 2 h in Tris-glycine buffer. The membranes were blocked in PBS-0.1% Tween 20 solution containing 3% BSA, probed with specific antibodies, and developed using ECL Blotting Substrate (Advansta, San Josè, CA, USA; K-12045-D20).
+ Open protocol
+ Expand
7

ACE2 Protein Extraction and Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gene-edited A549-ACE or Calu-3 cells seeded in six-well plate 24 h prior to experiment were chilled on ice for 10 min, and labeled with 2.5 mg/ml biotin (Thermo Fisher #21331) in PBS for 30 min on ice. Cells were quenched with 100 mM glycine in PBS three times, 10 min each. After washing with PBS, cells were lysed in RIPA buffer (Cell Signaling #9806S) with a cocktail of protease inhibitors (Sigma-Aldrich # S8830), and immunoprecipitated with Streptavidin agarose beads overnight at 4 °C. Beads were then washed three times with RIPA buffer, and eluted into 5× loading buffer (Beyotime #P0015L) at 95 °C for 10 min. After spinning at maximum speed for 10 min, the supernatants were harvested for western blotting using rabbit anti-ACE2 (Abcam #ab15348, 1:1000) as described above, and analyzed with the Odyssey CLx Imaging System and Image Studio 4.0 software. The un-immnoprecipitated lysates were used as a loading control.
+ Open protocol
+ Expand
8

Mushroom Protein Extraction and Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen mushroom pulp was defrosted at 4 °C and suspended in a 125 mM sodium citrate buffer, pH 5.3, containing 25 mM sodium l-ascorbate, 20 mM l-lysine, 50 mM l-proline. Again, PSMF and benzamidine hydrochloride pre-solved in DMSO were added (final concentration 1 mM), as well as two protease inhibitor cocktails (P8215 0.1% (v/v) and S8830 1 tab/L). The suspension was stirred for 15 min and subsequently centrifuged (14,500 rpm at 4 °C over 10 min). The pellet and the highly viscose triton-phase, covering the pellet, were discarded. The supernatant was adjusted to 20% (113 g/L) ammonium sulfate saturation and centrifuged (14,500 rpm at 4 °C over 10 min). The occurring pellet was discarded and PEG-4000 was dissolved to a concentration of 15% (m/v) in the supernatant at 4 °C. After further centrifugation (14,500 rpm, 4 °C, 10 min) the generated PEG phase (upper phase) containing the non-target proteins was discarded. This step was followed by the subsequent addition of another 5% (m/v) of PEG-4000 and centrifugation. This last step was repeated twice. During the extraction/purification process every 45 min a protease inhibitor mixture containing PMSF, benzamidine hydrochloride and the two cocktails P8215/S8830 (Sigma–Aldrich) pre-dissolved in DMSO was added.
+ Open protocol
+ Expand
9

Western Blot Protein Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RIPA lysate (R0278; Sigma-Aldrich; Merck KGaA) and a protease inhibitor were used to lyse cells (1×106) and extract total protein (S8830; Sigma-Aldrich; Merck KGaA). Each sample's total protein (50 µg per lane) was separated on a 10% SDS-PAGE at 120 V for around 1.5 hours. The protein suspension was mixed with 1X antibody solution, which was then transferred to a PVDF membrane and sealed with 5% skim milk for 1 hour at room temperature. The cell membranes were sealed with skim milk and then treated with a primary antibody overnight at 4°C (Sigma-Aldrich; Merck KGaA). The membranes were incubated with the matching secondary antibodies for 1 hour at room temperature the next day, after being washed with Tris-buffered saline and Tween 20 (TBST; Sigma-Aldrich, St. Louis, MO, USA). To find the proteins, Cell Signaling Technology, Inc.'s SignalFire™ ECL reagent (Catalog #6883) was used. Protein blot results were optical density analyzed and quantified using ImageLabTM software (version 3.0) from Bio-Rad Laboratories Inc.
+ Open protocol
+ Expand
10

Western Blot Analysis of Protein Lysates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells or xenograft tumors were lysed using RIPA (catalog V900854-100ML, VETEC) with 1 mM PMSF, and protease inhibitors (catalog S8830, Sigma‒Aldrich). Protein concentrations were quantified using the BCA protein test package (catalog P0010, Beyotime). After the proteins were separated, they were transferred to a PVDF membrane (catalog IPVH00010, Millipore), blocked with 5% nonfat milk, and incubated with the corresponding antibodies. On the second day, the bands were incubated with the corresponding secondary antibodies. HRP chemiluminescent substrates were used to visualize the immunoreactive bands (catalog BMU102-CN, Abbkine). The bands were quantified from the western blot results using Image Lab. The antibodies used in this study are listed in Supplementary Table 2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!